Pharmafile - Medical Communications News
Friday time! This past week has seen numerous potential breakthroughs including a prostate drug that could halt Parkinson’s disease as well as new MS...
Researchers at University College London have found that a commonly prescribed antidepressant, sertraline, works in unexpected ways, first relieving...
Novo Nordisk has unveiled new data for Tresiba, demonstrating that the drug lowered the overall risk of hypoglycaemia com with insulin glargine U300...
Biogen is planning a new trial of $1.7billion-a-year Spinraza to investigate much higher doses in spinal muscular atrophy (SMA) and thwart off...
Takeda and Lundbeck have announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has chosen to authorise their drug Trintellix (...
Roche has taken the opportunity at the ECTRIMS conference in Stockholm to reveal new longer-term data from three Phase 3 trials demonstrating that...
It’s Friday again and time for another rundown of the top most popular articles on Pharmafile.com this week. This past week saw Novo Nordisk launch...
Sir Mark Walport, Chief Executive of UK Research and Innovation (UKRI), the national funding agency responsible for science and research investment...
Ardelyx announced that it has received FDA approval for its NHE3 sodium transport inhibitor Isbrela (tenapanor) for the treatment of irritable bowel...
Johnson & Johnson subsidiary Janssen have announced results from its Phase 3 OPTIMUM trial showing superior efficacy to Sanofi’s Aubagio (...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
